Donanemab, the most effective treatment yet for the disease, will be banned on the health service despite regulators ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Oct. 17, 2024 — Researchers have cracked the code of plant-to-fungi communication in a new study. Using baker's yeast, the researchers discovered that the plant hormone strigolactone (SL ...

Molecular modelling encompasses all theoretical methods and computational techniques used to mimic and study the structure and behaviour of molecules, ranging from small chemical systems to large ...

Four anti-amyloid antibodies—lecanemab, aducanumab, gantenerumab, donanemab—cleared plaque from the brain in Phase 3 trials, but only two went on to receive traditional U.S. marketing approval. What ...

Molecular ecology is the use of molecular genetic tools to study ecological questions. Techniques such as microarrays and DNA markers are used to study the interactions and diversity of natural ...

Adding 75mg vial size would achieve greatest reduction in waste, representing annual savings of $99 million. HealthDay News — Annual wasteful spending on discarded lecanemab is anticipated to ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as momentous. Finally, for the first time, a drug had slowed the ...

Eisai will request a reconsideration of this decision under Section 60 of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia.